Prognostic significance of an autophagy-related long non-coding RNA signature in patients with oral and oropharyngeal squamous cell carcinoma

被引:26
|
作者
Jiang, Qingkun [1 ]
Xue, Danfeng [1 ]
Shi, Fanzhe [1 ]
Qiu, Jiaxuan [1 ]
机构
[1] Nanchang Univ, Dept Oral & Maxillofacial Surg, Affiliated Hosp 1, 17 Yongwai Zheng St, Nanchang 330006, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
oral squamous cell carcinoma; oropharyngeal squamous cell carcinoma; autophagy; long non-coding RNAs; survival; prognosis; signature; LNCRNA-HOTAIR; PROTEIN; ACTIVATION; MECHANISMS; EXPRESSION; RESISTANCE; APOPTOSIS; PATHWAY; DEATH; AKT;
D O I
10.3892/ol.2020.12290
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Traditional clinicopathological indices are insufficient in predicting the prognosis of patients diagnosed with oral and oropharyngeal squamous cell carcinoma (OSCC/OPSCC). Notably, autophagy and long non-coding RNAs (lncRNAs) regulate the development and progression of various types of cancer. The present study aimed to assess the association between autophagy-related lncRNAs and the prognosis of patients diagnosed with OSCC/OPSCC. Gene sequencing and clinicopathological data of patients with OSCC/OPSCC were downloaded from The Cancer Genome Atlas database, while gene set functional classification was downloaded from the Gene Set Enrichment Analysis database. Out of the 413 transcriptome data samples and 402 clinicopathological data samples retrieved, a total of nine autophagy-related lncRNAs, including PTCSC2, AC099850.3, LINC01963, RTCA-AS1, AP002884.1, UBAC2-AS1, AL512274.1, MIR600HG and AL354733.3, were screened. This was geared towards establishing a signature through gene co-expression network, univariate and Least Absolute Shrinkage and Selection Operator Cox regression analyses. Based on this signature, the patients were subdivided into a high-risk group and a low-risk group. Kaplan-Meier survival analysis revealed that the overall survival of the high-risk group was significantly lower than that of the low-risk group. Furthermore, principal components analysis demonstrated that the patients diagnosed with OSCC/OPSCC could be distinguished into low-survival and high-survival groups according to the signature. Univariate and multivariate Cox regression analyses of clinicopathological data and the signature revealed that the signature could potentially be used as an independent prognostic factor for OSCC/OPSCC. In addition, reverse transcription-quantitative PCR analysis of clinical samples demonstrated the validity of the signature. In summary, the present study revealed that the signature based on autophagy-related lncRNAs potentially acts as an independent prognostic indicator for patients with OSCC/OPSCC. Furthermore, it promotes research on targeted diagnosis and treatment of patients diagnosed with OSCC/OPSCC.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Prognostic significance of overexpressed long non-coding RNA TUG1 in patients with clear cell renal cell carcinoma
    Wang, P. -Q.
    Wu, Y. -X.
    Zhong, X. -D.
    Liu, B.
    Qiao, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (01) : 82 - 86
  • [32] Identification of an autophagy-related prognostic signature in head and neck squamous cell carcinoma
    Jiang, Yue
    Li, Yuanyuan
    Ge, Han
    Wu, Yaping
    Zhang, Yuchao
    Guo, Songsong
    Zhang, Ping
    Cheng, Jie
    Wang, Yanling
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2021, 50 (10) : 1040 - 1049
  • [33] A novel autophagy-related long non-coding RNAs prognostic risk score for clear cell renal cell carcinoma
    Fucai Tang
    Zhicheng Tang
    Zechao Lu
    Yueqiao Cai
    Yongchang Lai
    Yuexue Mai
    Zhibiao Li
    Zeguang Lu
    Jiahao Zhang
    Ze Li
    Zhaohui He
    BMC Urology, 22
  • [34] A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma
    Huang, Ge
    Huang, Qing
    Xie, Zilu
    Zhou, Huihui
    Cao, Jiangbo
    Shi, Long
    Yang, Mingwei
    CANCER BIOMARKERS, 2019, 26 (03) : 239 - 247
  • [35] Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma
    Qu, Le
    Wang, Ze-lin
    Chen, Qi
    Li, Yao-ming
    He, Hao-wei
    Hsieh, James J.
    Xue, Song
    Wu, Zhen-jie
    Liu, Bing
    Tang, Hao
    Xu, Xiao-feng
    Xu, Feng
    Wang, Jie
    Bao, Yi
    Wang, An-bang
    Wang, Dong
    Yi, Xiao-ming
    Zhou, Zhong-kui
    Shi, Chang-jie
    Zhong, Ke
    Sheng, Zheng-cheng
    Zhou, Yu-lin
    Jiang, Jun
    Chu, Xiao-yuan
    He, Jia
    Ge, Jing-ping
    Zhang, Zheng-yu
    Zhou, Wen-quan
    Chen, Cheng
    Yang, Jian-hua
    Sun, Ying-hao
    Wang, Lin-hui
    EUROPEAN UROLOGY, 2018, 74 (06) : 756 - 763
  • [36] Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma
    Yang, Cai
    Mei, Hongxiang
    Peng, Liang
    Jiang, Fulin
    Xie, Bingjie
    Li, Juan
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2020, 2020
  • [37] A Seven-Autophagy-Related Long Non-Coding RNA Signature Can Accurately Predict the Prognosis of Patients with Renal Cell Carcinoma
    Du, Ruoyang
    Xiao, Qing
    Huang, Jianfeng
    Feng, Wubing
    Zheng, Xiangqi
    Yi, Tong
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 8143 - 8157
  • [38] A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma
    Zhang, Jiarun
    Zhang, Xiaotong
    Piao, Chiyuan
    Bi, Jianbin
    Zhang, Zhe
    Li, Zhenhua
    Kong, Chuize
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 118
  • [39] The new horizon of biomarker in melanoma patients A study based on autophagy-related long non-coding RNA
    Li, Zhehong
    Wei, Junqiang
    Zheng, Honghong
    Zhang, Yafang
    Song, Mingze
    Cao, Haiying
    Jin, Yu
    MEDICINE, 2022, 101 (01)
  • [40] A novel marker based on necroptosis-related long non-coding RNA for forecasting prognostic in patients with clear cell renal cell carcinoma
    Lv, Jinxing
    Xu, Qinghui
    Wu, Guoqing
    Hou, Jian
    Yang, Guang
    Tang, Cheng
    Qu, Genyi
    Xu, Yong
    FRONTIERS IN GENETICS, 2022, 13